NCT07644897
- Conditions
- Immune Checkpoint Inhibitor, Immune-related Adverse Event, Melanoma, +11 more
- Locations
-
- Sun yat-sen uniersity Guangzhou, Guangdong, China
- Nanshan hospital Shenzhen, Guangdong, China
Clinical trial condition
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
NCT07644897
NCT05361174
NCT04771520
NCT05076760
NCT04855435
NCT04658303
NCT05588453
NCT06743126
NCT06831071
NCT05655312